Creative Planning’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $371K | Buy |
13,730
+3,299
| +32% | +$111K | ﹤0.01% | 3254 |
|
|
2025
Q4 | $447K | Buy |
10,431
+1,956
| +23% | +$73.7K | ﹤0.01% | 2936 |
|
|
2025
Q3 | $240K | Buy |
+8,475
| New | +$254K | ﹤0.01% | 3324 |
|
|
2025
Q2 | – | Sell |
-15,591
| Closed | -$280K | – | 3779 |
|
|
2025
Q1 | $280K | Buy |
15,591
+15,538
| +29,317% | +$315K | ﹤0.01% | 2816 |
|
|
2024
Q4 | $891 | Buy |
+53
| New | +$1.02K | ﹤0.01% | 3543 |
|
|
2023
Q4 | – | Sell |
-1,175
| Closed | -$12.7K | – | 3030 |
|
|
2023
Q3 | $12.7K | Buy |
+1,175
| New | +$14.1K | ﹤0.01% | 2628 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$36K | – | 2201 |
|
|
2021
Q3 | $36K | Hold |
1,000
| – | – | ﹤0.01% | 2020 |
|
|
2021
Q2 | $43K | Sell |
1,000
-1,020
| -50% | -$38.5K | ﹤0.01% | 1950 |
|
|
2021
Q1 | $69K | Buy |
2,020
+1,000
| +98% | +$39.6K | ﹤0.01% | 2312 |
|
|
2020
Q4 | $36K | Sell |
1,020
-1,000
| -50% | -$28.9K | ﹤0.01% | 2134 |
|
|
2020
Q3 | $48K | Hold |
2,020
| – | – | ﹤0.01% | 1905 |
|
|
2020
Q2 | $37K | Buy |
2,020
+20
| +1% | +$360 | ﹤0.01% | 1786 |
|
|
2020
Q1 | $31K | Hold |
2,000
| – | – | ﹤0.01% | 1689 |
|
|
2019
Q4 | $43K | Hold |
2,000
| – | – | ﹤0.01% | 1834 |
|
|
2019
Q3 | $37K | Hold |
2,000
| – | – | ﹤0.01% | 1817 |
|
|
2019
Q2 | $52K | Hold |
2,000
| – | – | ﹤0.01% | 1811 |
|
|
2019
Q1 | $51K | Hold |
2,000
| – | – | ﹤0.01% | 1775 |
|
|
2018
Q4 | $46K | Hold |
2,000
| – | – | ﹤0.01% | 1717 |
|
|
2018
Q3 | $64K | Buy |
2,000
+1,000
| +100% | +$30K | ﹤0.01% | 1847 |
|
|
2018
Q2 | $28K | Hold |
1,000
| – | – | ﹤0.01% | 1887 |
|
|
2018
Q1 | $35K | Sell |
1,000
-100
| -9% | -$4K | ﹤0.01% | 1850 |
|
|
2017
Q4 | $43K | Buy |
1,100
+100
| +10% | +$3.81K | ﹤0.01% | 1806 |
|
|
2017
Q3 | $25K | Sell |
1,000
-31
| -3% | -$754 | ﹤0.01% | 1824 |
|
|
2017
Q2 | $28K | Buy |
1,031
+31
| +3% | +$848 | ﹤0.01% | 2938 |
|
|
2017
Q1 | $33K | Hold |
1,000
| – | – | ﹤0.01% | 2771 |
|
|
2016
Q4 | $24K | Hold |
1,000
| – | – | ﹤0.01% | 2963 |
|
|
2016
Q3 | $37K | Hold |
1,000
| – | – | ﹤0.01% | 2599 |
|
|
2016
Q2 | $22K | Hold |
1,000
| – | – | ﹤0.01% | 2730 |
|
|
2016
Q1 | $21K | Sell |
1,000
-400
| -29% | -$9.87K | ﹤0.01% | 2726 |
|
|
2015
Q4 | $42K | Buy |
1,400
+400
| +40% | +$12.1K | ﹤0.01% | 2261 |
|
|
2015
Q3 | $25K | Hold |
1,000
| – | – | ﹤0.01% | 2563 |
|
|
2015
Q2 | $32K | Hold |
1,000
| – | – | ﹤0.01% | 1050 |
|
|
2015
Q1 | $36K | Buy |
+1,000
| New | +$27.4K | ﹤0.01% | 2252 |
|
|
2014
Q4 | – | Sell |
-64
| Closed | -$1K | – | 4312 |
|
|
2014
Q3 | $1K | Buy |
+64
| New | +$1.81K | ﹤0.01% | 3859 |
|
Other funds holding RIGL
AC
VCM
Creative Planning's RIGL Position: Q1 2026 in Review
Creative Planning increased its Rigel Pharmaceuticals (RIGL) stake by 32% in Q1 2026, buying an estimated $111K and bringing the position to 13,730 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #3254.
Creative Planning first reported a position in RIGL in Q3 2014 and has held it in 34 quarters since. The position peaked at $447K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.
- Creative Planning held 13,730 shares of Rigel Pharmaceuticals worth $371K as of Q1 2026.
- Creative Planning bought 3,299 Rigel Pharmaceuticals shares in Q1 2026, an estimated $111K.
- Rigel Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #3254 holding.
- Creative Planning first reported a position in Rigel Pharmaceuticals in Q3 2014 and has held it in 34 quarters since.
- Creative Planning's Rigel Pharmaceuticals position peaked at $447K in Q4 2025.
- 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.